Healthcare & Life Sciences

USPTO Surgical Instrument Lockout Features Patent Granted

The USPTO has granted patent US12582397B2 for a surgical instrument with lockout features, assigned to Cilag GmbH International. The patent describes a lockout assembly that prevents critical components from advancing until a surgical staple cartridge unlocks it.

ANSM Safety Alert: Kwik-Stik and Lyfo Disk Campylobacter jejuni Controls

The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety alert regarding bacteriology controls for Kwik-Stik and Lyfo Disk Campylobacter jejuni products from Microbiologics. This notice informs laboratories of a security action implemented by the manufacturer.

ANSM Safety Information: Urology/Gynecology Suction Device

The French ANSM has been informed of a lot recall initiated by Clinical Innovations, LLC for their KIWI Omni Vacuum Delivery System suction device. This safety action is registered under number R2607844 and is directed at pharmacies and healthcare facilities.

ANSM Safety Alert: Manual Ventilator

The French ANSM has updated a safety alert regarding manual ventilators (Bavu) manufactured by Intersurgical. This update expands the scope of devices affected by a previous safety action initiated in May 2025, with users receiving updated correspondence.

Dr. Angus J. Michaels Voluntary Practice Restrictions Agreement

The Massachusetts Board of Registration in Medicine and Dr. Angus J. Michaels have entered into a Voluntary Agreement for Practice Restrictions (VAPR). This agreement replaces a previous non-practice agreement and restricts Dr. Michaels' patient encounters to telehealth only, prohibiting in-person visits.

New Jersey Health Recognizes World Tuberculosis Day

The New Jersey Department of Health (NJDOH) issued a notice recognizing March 24 as World Tuberculosis Day. The notice highlights the ongoing impact of tuberculosis, provides statistics for New Jersey and globally, and reiterates the state's commitment to TB prevention and control efforts.

New Jersey Department of Health Recognizes World TB Day

The New Jersey Department of Health issued a notice recognizing March 24 as World TB Day. The notice highlights the ongoing efforts and impact of TB prevention and control in New Jersey, noting 342 new cases in 2024 and providing funding updates for local health departments.

DEA Omaha Seizes 70 Pounds of Methamphetamine

The DEA's Omaha Division announced the seizure of 70 pounds of methamphetamine. This action highlights ongoing efforts by law enforcement agencies to combat illicit drug trafficking.

DEA Phoenix Seizes 3 Million Fentanyl Pills in Arizona

The DEA Phoenix Division announced the seizure of nearly three million fentanyl pills in Arizona as part of Phase II of Operation FentanylFreeAmerica. This significant bust highlights ongoing efforts to combat the flow of illicit synthetic opioids.

DEA Memphis Arrests and Seizures

The DEA announced significant arrests and seizures in Memphis, Tennessee, including fentanyl, cocaine, meth, and numerous firearms. Administrator Cole provided remarks on the operation's success in combating drug trafficking and enhancing public safety.

USPTO Patent Grant: RAS Oncoprotein Inhibitors

The USPTO has granted patent US12582660B2 to the University of Louisville Research Foundation, Inc. for inhibitors of the RAS oncoprotein, methods of making, and methods of use thereof. The patent covers compounds useful in treating diseases associated with activating mutations in RAS, particularly cancer.

USPTO Patent Grant for Tumor Diagnosis and Treatment

The USPTO has granted patent US12583937B2 to Genentech, Inc. for compositions and methods related to the diagnosis and treatment of tumors in mammals. The patent, filed on March 16, 2022, includes 6 claims.

USPTO Grants Patent for Anti-CD73 Antibody and Use

The United States Patent and Trademark Office (USPTO) has granted patent US12583933B2 to BIOTHEUS INC. for an anti-CD73 antibody and its use in enhancing immune response and treating tumors. The patent was filed on August 28, 2020, and is effective March 24, 2026.

USPTO Patent Grant for Caged-Degron Molecular Feedback Circuits

The USPTO has granted patent US12583896B2 to The Regents of the University of California for caged-degron-based molecular feedback circuits. The patent covers methods of modulating signaling pathways in cells using these circuits, with a filing date of January 6, 2020.

USPTO Patent Grant for LRP6 Protein Binding Antibodies

The USPTO has granted a patent (US12583919B2) to Antlera Therapeutics Inc. for antibodies that specifically bind to LRP6 proteins and methods of their use. The patent was filed on August 14, 2020, and is set to be granted on March 24, 2026.

USPTO Patent Grant: Modified Plasma Clotting Factor VIII

The USPTO has granted patent US12583907B2 to AAVnerGene, INC. for modified human factor VIII polypeptides with enhanced activity. These polypeptides and their encoding viral vectors are intended for treating FVIII deficiencies, such as hemophilia A.

USPTO Patent Grant for Cancer Diagnosis using Anti-BAG2 Antibody

The USPTO has granted a patent (US12583915B2) to Medpacto, Inc. for methods of diagnosing cancer using an anti-BAG2 antibody. The patent covers compositions comprising antibodies that specifically bind to BAG2 polypeptides or fragments thereof.

USPTO Patent Grant: Antibody Inhibitors for Staphylococcus Aureus Treatment

The USPTO has granted patent US12583913B2 for antibody inhibitors targeting Staphylococcus aureus, specifically coagulases SC and vWbp. This patent covers therapeutic methods and detection techniques utilizing these monoclonal antibodies.

USPTO Patent Grant for T Cell Antigen Receptor Complex

The USPTO has granted patent US12583910B2 to Tsinghua University for a T cell antigen receptor complex and its preparation method. This patent covers antibodies, T cell receptors, and immune cells designed to recognize pMHC complexes and activate T cells for therapeutic use.

USPTO Patent Granted for Anti-Pro/Latent Myostatin Antibodies

The USPTO has granted a patent (US12582712B2) to Scholar Rock, Inc. for a method of making anti-pro/latent myostatin antibodies. The patent covers antibodies that specifically bind proMyostatin and/or latent Myostatin and their uses.

USPTO Patent Grant: DNA-binding domain transactivators

The USPTO has granted a patent (US12583902B2) to the University of Massachusetts for DNA-binding domain transactivators and their uses. The patent covers recombinant adeno-associated viruses (rAAVs) designed to modify target gene expression in cells.

USPTO Patent US12583917B2: IL17A Antibodies for Veterinary Use

The USPTO has granted patent US12583917B2 to Elanco US Inc. for IL17A antibodies and antagonists intended for treating conditions in animals, including companion animals. The patent details specific antibody embodiments and IgG Fc variant polypeptides designed to reduce immune responses.

Mutant Myocilin Disease Model Patent Granted

The USPTO has granted Regeneron Pharmaceuticals, Inc. a patent (US12582104B2) for a mutant myocilin disease model. This patent covers non-human animal models engineered to express human myocilin, intended for assessing therapeutic reagents for glaucoma.

Amgen Inc. Patent for KRAS G12C Inhibitor Cancer Therapy

The USPTO has granted Amgen Inc. a patent (US12582657B2) for a combination therapy involving a KRAS G12C inhibitor and other agents for treating cancers. The patent covers pharmaceutical compositions and methods of treatment.

Bi-specific Peptides for Cancer Treatment Granted Patent

The USPTO has granted a patent (US12583888B2) to the University of Tartu for bi-specific peptides designed to target cancer cells and the extracellular matrix. These peptides bind to fibronectin extra domain B (FN-EDB) and/or tenascin-C C domain (TNC-C). The patent was granted on March 24, 2026.

USPTO Patent Grant US12583892B2: Conus Peptides for Neurodegenerative Conditions

The USPTO has granted patent US12583892B2 to Technion Research and Development Foundation Limited for modified Conantokin peptides and their use in treating neurodegenerative conditions. The patent covers specific peptide forms, nucleic acids encoding them, and compositions for modulating NMDA receptors.

USPTO Patent Grant for Peptides Treating Type 1 Diabetes

The USPTO has granted patent US12583891B2 to PHOENIX ALPHA for peptides and methods used in the treatment of type 1 diabetes. The patent covers specific peptide sequences and their application in generating cytolytic CD4+ T cells.

USPTO Grants Patent for Bis-biguanide Compounds in Cancer Management

The USPTO has granted a patent (US12582618B2) to Emory University for bis-biguanide compounds and pharmaceutical compositions for managing cancer, particularly lung cancer. The patent covers methods of treatment and related compositions, with an effective grant date of March 24, 2026.

USPTO Patent Grant: B-RAF Kinase Inhibitor Solid Dispersion

The USPTO has granted a patent to BeiGene, Ltd. for a stable solid dispersion of a B-RAF kinase dimer inhibitor, Compound 1. The patent covers the composition, methods of preparation, and uses of this solid dispersion, as well as a crystalline form of Compound 1.

Moderna Cancer Vaccines Patent Grant

The USPTO has granted patent US12582609B2 to ModernaTX, Inc. for cancer ribonucleic acid (RNA) vaccines. The patent covers cancer RNA vaccines, methods of use, and compositions. This grant is a routine notification of intellectual property protection.

Patent: ROS-detonable Nanoclusters for Anti-Restenotic Therapy

The USPTO has granted a patent (US12582613B2) for biomimetic, reactive oxygen species-detonable nanoclusters designed for anti-restenotic therapy. The technology, assigned to the University of Virginia Patent Foundation, involves nanoclusters with self-assembled cores and biomimetic membrane coatings that can deliver anti-restenotic drugs.

USPTO Patent Grant: Theranostic Agents for PSMA Positive Cancers

The USPTO has granted a patent (US12582728B2) to Memorial Sloan Kettering Cancer Center for theranostic agents targeting PSMA positive cancers. The patent covers compositions and methods for detecting and treating cancer using novel radiohalogenated PSMA targeting agents for diagnostic imaging and radiation therapy.

USPTO Patent Grant: Kit for Producing and Storing Radiopharmaceuticals

The USPTO has granted patent US12582729B2 to Wake Forest University Health Sciences for a kit technology designed for the production and long-term storage of Zr-89-PET radiopharmaceuticals. The patent covers improved stability for radiopharmaceuticals and a method for their production.

USPTO Grants Patent for ACE Inhibitor and Blood Pressure-Lowering Agent

The USPTO has granted a patent (US12582146B2) to MARUZEN PHARMACEUTICALS CO., LTD. for an angiotensin-converting enzyme inhibitor and blood pressure-lowering agent containing a specific compound. The patent also covers beverages and food products incorporating this compound.

USPTO Patent Granted for Dissociative Disorder Treatment Methods

The USPTO has granted a patent (US12582616B2) to The Board of Trustees of the Leland Stanford Junior University for methods of treating dissociative disorders. The patent covers agents that modulate neural activity in the posteromedial cortex to treat these conditions.

USPTO Patent Grant: Topical Anti-inflammatory Composition with Zileuton

The USPTO has granted a patent (US12582598B2) to QURIENT CO., LTD. for a topical anti-inflammatory pharmaceutical composition comprising Zileuton. The patent covers the composition, its uses, and methods of preparation.

Bifunctional compounds for degrading BTK via ubiquitin pathway

The USPTO has granted patent US12582722B2 to Nurix Therapeutics, Inc. for bifunctional compounds designed to degrade Bruton's tyrosine kinase (BTK) through the ubiquitin proteolytic pathway. The patent covers novel compounds and pharmaceutical compositions for treating various diseases.

NCDHHS and PRN Groundbreaking for New Respite Center

The North Carolina Department of Health and Human Services (NCDHHS) announced a groundbreaking event for a new respite center in Cabarrus County, funded with nearly $1 million from NCDHHS. The center, operated by Promise Resource Network (PRN), will provide a peaceful space for residents to manage their mental health.

Pennsylvania Invests $6M for Free Student Period Products, Proposes $3M More

The Shapiro Administration has invested $6 million over two years to provide free period products in Pennsylvania schools and has proposed an additional $3 million for the 2026-27 budget. This initiative aims to improve health equity and keep students in the classroom by addressing the affordability and accessibility of essential hygiene products.

HHS Adopts Standards for Health Care Claims Attachments and Electronic Signatures

The Department of Health and Human Services (HHS) has finalized standards for health care claims attachments transactions and electronic signatures. This rule aims to streamline administrative processes within the healthcare industry by adopting new standards for these transactions.

NH Board of Pharmacy - Emergency Suspension of Pharmacist License

The New Hampshire Board of Pharmacy has issued an emergency order suspending the license of pharmacist Justin Eric Lachance. The suspension follows findings of suspected diversion of controlled substances, including Clonazepam and Zolpidem, observed via Walgreens surveillance and confessed by the licensee.

Walmart Pharmacy Disciplinary Final Order

The New Hampshire Board of Pharmacy issued a disciplinary final order against Walmart Pharmacy concerning multiple locations. The order details the procedures and timelines for filing petitions for rehearing and the right to appeal the decision to the New Hampshire Supreme Court.

Andrew Merdinyan License Emergency Suspension Order

The New Hampshire Board of Pharmacy has issued an emergency suspension order for the license of Andrew Merdinyan, a Registered Pharmacy Technician. The suspension is due to findings of probable cause that the licensee engaged in conduct posing an imminent danger to public health, safety, and welfare, including admitting to taking controlled medications from a pharmacy.

Felicia Dern - Voluntary Surrender of Pharmacy Tech License

The New Hampshire Board of Pharmacy has accepted the voluntary surrender of Felicia Dern's Registered Pharmacy Technician license (PHT-130661). This action follows allegations of drug diversion and substance misuse disorder, which led to her termination from Rite Aid.

Andrew Merdinyan - Pharmacy Technician License Surrender

The New Hampshire Board of Pharmacy has accepted the voluntary surrender of Andrew Merdinyan's pharmacy technician license (PhT-131188) due to allegations of controlled drug diversion. Merdinyan allegedly diverted approximately 1,236 tablets/capsules from a Walgreens pharmacy.

Georgia Pharmacy Board Actions - February 2026

The Georgia Board of Pharmacy has issued a list of actions taken in February 2026. These actions include a voluntary surrender for a technician and a consent order for a facility, Xttrium Laboratories, Inc. Specific details on the nature of the consent order and surrender are pending further documentation.

GA Board of Pharmacy Actions - February 2025

The Georgia Board of Pharmacy has issued a list of actions taken in February 2025. These actions include a voluntary cease and desist order for Steri-Tek PHWH004241 and a consent order for S2 Medical Supply, LLC (PHDME000685). Specific details on the nature of violations or penalties are not provided in this summary.

Georgia Board of Pharmacy Consent Orders and Revoked Registrations

The Georgia Board of Pharmacy has issued consent orders for Musely Compounding Pharmacy East LLC and Cornerstone Medical, Inc. Additionally, registrations for technicians Amira Jayde Brooks and Cythnia Elaine Brannon have been revoked.

Georgia Pharmacy Board Actions - January 2026

The Georgia Board of Pharmacy has issued its January 2026 Public Board Actions List. This list details enforcement actions taken against licensees, including the summary suspension of a facility's license and the lifting of a pharmacist's suspension. Specific licensee names and license numbers are provided for each action.

GA Board of Pharmacy Actions - January 2025

The Georgia Board of Pharmacy has revoked the registration of Yental Breanna Alford (PHTC051190) in its January 2025 public actions list. This action pertains to a pharmacy technician.